{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:08:17Z","timestamp":1793995697901,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272681"],"award-info":[{"award-number":["82272681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bbadis.2024.167123","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T13:20:05Z","timestamp":1710249605000},"page":"167123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1+ cancer-associated fibroblast in gastric cancer"],"prefix":"10.1016","volume":"1870","author":[{"given":"Xiya","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hena","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbadis.2024.167123_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167123_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114012","article-title":"Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2024.167123_bb0015","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1038\/nrdp.2017.36","article-title":"Gastric adenocarcinoma","volume":"3","author":"Ajani","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167123_bb0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10120-021-01182-9","article-title":"Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?","volume":"24","author":"Roviello","year":"2021","journal-title":"Gastric Cancer"},{"issue":"9742","key":"10.1016\/j.bbadis.2024.167123_bb0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2024.167123_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2020.02.038","article-title":"Tumour mutational burden as a biomarker for immunotherapy: current data and emerging concepts","volume":"131","author":"Fumet","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167123_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40164-019-0129-x","article-title":"Immunotherapy in extensive small cell lung cancer","volume":"8","author":"Verma","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2024.167123_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0045","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1038\/s41467-021-23356-w","article-title":"Intratumoral CXCR5(+)CD8(+)T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2024.167123_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102015","article-title":"The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target","volume":"86","author":"Gambardella","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167123_bb0055","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer","volume":"68","author":"Lin","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100888","article-title":"Classification of gastric cancers based on immunogenomic profiling","volume":"14","author":"Liu","year":"2021","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0065","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1186\/s12885-021-09065-z","article-title":"Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167123_bb0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","article-title":"Tumor microenvironment characterization in gastric Cancer identifies prognostic and Immunotherapeutically relevant gene signatures","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167123_bb0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00262-020-02525-8","article-title":"Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications","volume":"69","author":"Zhou","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167123_bb0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167123_bb0085","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of Cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167123_bb0090","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167123_bb0095","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"issue":"30","key":"10.1016\/j.bbadis.2024.167123_bb0100","doi-asserted-by":"crossref","first-page":"E3091","DOI":"10.1073\/pnas.1411679111","article-title":"Stromal response to hedgehog signaling restrains pancreatic cancer progression","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167123_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbadis.2024.167123_bb0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization","volume":"11","author":"Gaujoux","year":"2010","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167123_bb0120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder Cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.bbadis.2024.167123_bb0130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbadis.2024.167123_bb0140","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2024.167123_bb0145","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12(4):R41","author":"Mermel","year":"2011","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13073-017-0484-3","article-title":"Actionable gene-based classification toward precision medicine in gastric cancer","volume":"9","author":"Ichikawa","year":"2017","journal-title":"Genome Med."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167123_bb0155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167123_bb0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167123_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.3458","article-title":"Regulators of genetic risk of breast cancer identified by integrative network analysis","volume":"48","author":"Castro","year":"2016","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0972-8","article-title":"Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer","volume":"18","author":"Ham","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2024.167123_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","article-title":"Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer","volume":"454","author":"Zhai","year":"2019","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167123_bb0185","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2024.167123_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0195","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0200","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 signaling in Cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0210","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/s41467-018-05982-z","article-title":"PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-021-01934-6","article-title":"Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt\/beta-catenin pathway","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167123_bb0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41419-019-1581-6","article-title":"Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/ERbeta\/Bcl-2 signalling","volume":"10","author":"Long","year":"2019","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167123_bb0225","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"23","key":"10.1016\/j.bbadis.2024.167123_bb0230","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-16-1201","article-title":"Chemoresistance in pancreatic Cancer is driven by stroma-derived insulin-like growth factors","volume":"76","author":"Ireland","year":"2016","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167123_bb0235","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbadis.2017.12.021","article-title":"Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF\/IGF-1\/ANXA2 signaling","volume":"1864","author":"Yi","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167123_bb0240","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/labinvest.2015.82","article-title":"Clinical significance of the integrin alpha6beta4 in human malignancies","volume":"95","author":"Stewart","year":"2015","journal-title":"Lab. Invest."},{"issue":"6322","key":"10.1016\/j.bbadis.2024.167123_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167123_bb0250","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41556-019-0352-z","article-title":"HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity","volume":"21","author":"Wu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167123_bb0255","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ccell.2021.01.003","article-title":"Mutant p53 suppresses innate immune signaling to promote tumorigenesis","volume":"39","author":"Ghosh","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167123_bb0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ebiom.2018.05.019","article-title":"TP53 mutation as potential negative predictor for response of anti-CTLA-4 therapy in metastatic melanoma","volume":"32","author":"Xiao","year":"2018","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167123_bb0265","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","article-title":"ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade","volume":"24","author":"Shen","year":"2018","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167123_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070678","article-title":"ARID1A mutations are associated with increased immune activity in gastrointestinal cancer","volume":"8","author":"Li","year":"2019","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.bbadis.2024.167123_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003414","article-title":"Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers","volume":"9","author":"Kim","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0280","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12964-019-0397-4","article-title":"Subtyping of microsatellite instability-high colorectal cancer","volume":"17","author":"Hu","year":"2019","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167123_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003100","article-title":"CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167123_bb0290","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12979","article-title":"Tumour microenvironment-based molecular profiling reveals ideal candidates for high-grade serous ovarian cancer immunotherapy","volume":"54","author":"Lu","year":"2021","journal-title":"Cell Prolif."},{"issue":"8","key":"10.1016\/j.bbadis.2024.167123_bb0295","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155148","article-title":"Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-beta signaling enables PD-L1-mediated tumor eradication","volume":"132","author":"Horn","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167123_bb0300","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910515","article-title":"Targeting TGFbetaR2-mutant tumors exposes vulnerabilities to stromal TGFbeta blockade in pancreatic cancer","volume":"11","author":"Huang","year":"2019","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0305","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-019-10369-9","article-title":"LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8(+) T cell tumor-infiltration impairing anti-PD1 therapy","volume":"10","author":"Pascual-Garcia","year":"2019","journal-title":"Nat. Commun."},{"issue":"50","key":"10.1016\/j.bbadis.2024.167123_bb0310","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167123_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.10.020","article-title":"Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade","volume":"53","author":"Bonavita","year":"2020","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bbadis.2024.167123_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166540","article-title":"YAP1-TEAD1 mediates the perineural invasion of prostate cancer cells induced by cancer-associated fibroblasts","volume":"1868","author":"Shen","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"14","key":"10.1016\/j.bbadis.2024.167123_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143482","article-title":"DDR2 expression in Cancer-associated fibroblasts promotes ovarian Cancer tumor invasion and metastasis through Periostin-ITGB1","volume":"14","author":"Akinjiyan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bbadis.2024.167123_bb0330","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jamaoncol.2016.4975","article-title":"Androgen receptor function and androgen receptor-targeted therapies in breast Cancer: a review","volume":"3","author":"Kono","year":"2017","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167123_bb0335","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167123_bb0340","first-page":"3098","article-title":"Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathways","volume":"11","author":"Bahrami","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167123_bb0345","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12249","article-title":"M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K\/AKT\/mTOR pathway","volume":"24","author":"Lv","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167123_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071647","article-title":"NOX4 signaling mediates Cancer development and therapeutic resistance through HER3 in ovarian cancer cells","volume":"10","author":"Liu","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167123_bb0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s43018-019-0007-9","article-title":"Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade","volume":"1","author":"Ajona","year":"2020","journal-title":"Nat. Cancer"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167123_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159912","article-title":"Pancreatic fibroblasts stimulate the motility of pancreatic Cancer cells through IGF1\/IGF1R signaling under hypoxia","volume":"11","author":"Hirakawa","year":"2016","journal-title":"PloS One"},{"issue":"15","key":"10.1016\/j.bbadis.2024.167123_bb0365","doi-asserted-by":"crossref","first-page":"12491","DOI":"10.1074\/jbc.M111.304170","article-title":"Cross-talk between integrin alpha6beta4 and insulin-like growth factor-1 receptor (IGF1R) through direct alpha6beta4 binding to IGF1 and subsequent alpha6beta4-IGF1-IGF1R ternary complex formation in anchorage-independent conditions","volume":"287","author":"Fujita","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:23:35Z","timestamp":1762323815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0925443924001121"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167123","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1+ cancer-associated fibroblast in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167123"}}